APOTHEEK LOPPEM
ActiveAPOTHEEK LOPPEM has been active since 1983 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €427k and a net result of €-8k. Equity is growing by ~4% per year across the filed fiscal years. Its solvency ranks better than 79% of 4123 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
66
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability32▲+10
Solvency91▼-2
Growth52=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 1.86 against 1.83 in 2024; short-term debt: 28.1% and cash: 7.3% of total assets), and 34.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year €-8k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
22 d late
2023
12 d late
2022
3 d early
2021
41 d early
2020
5 d early
2019
27 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€-8k▲ 51.7%
2024 · €-17k
2018: €19k
2019: €28k
2020: €88k
2021: €60k
2022: €19k
2023: €40k
2024: €-17k
2018 → 2025
Working capital
€158k▲ 1.6%
2024 · €155k
2018: €-30k
2019: €64k
2020: €142k
2021: €197k
2022: €204k
2023: €159k
2024: €155k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€493k-€512k▲ 3.9%€452k▼ 11.7%€435k▼ 3.8%€427k▼ 1.9%
Operating result€80k-€26k▼ 67.9%€54k▲ 112%€-10k€2k
Net result€60k-€19k▼ 67.7%€40k▲ 109%€-17k€-8k▲ 51.7%
Result per fiscal year
Operating resultNet result
The operating result returns to profit in 2025: €2k after a loss of €10k in 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €648k
Fixed assets
€308k▲ 4.6%
Current assets
€340k▼ 0.4%
Equity and liabilities €648k
Equity
€427k▼ 1.9%
Provisions
€12k▼ 10.6%
Debt
€209k▲ 11.8%
The debt ratio rises from 29.4% to 32.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€24k▲
2024 · €8k
Cash flow
€13k▲
2024 · €1k
Solvency
65.8%▼
2024 · 68.4%
Current ratio
1.86▲
2024 · 1.83
Quick ratio
1.07▲
2024 · 0.96
Debt / equity
0.49▲
2024 · 0.43
ROE
-1.9%▲
2024 · -3.9%
ROA
-1.3%▲
2024 · -2.7%
Interest coverage
1.81▲
2024 · 0.79
Debt
€209k▲
2024 · €187k
Debt ≤ 1 year
€182k▼
2024 · €186k
Debt > 1 year
€24k
Staff costs
€103k▲
2024 · €95k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€636k€648k▲
Fixed assets21/28€295k€308k▲
Tangible fixed assets22/27€295k€308k▲
Land and buildings22€286k€272k▼
Plant, machinery and equipment23€8k€7k▼
Leasing and similar rights25-€30k
Current assets29/58€341k€340k▼
Stocks and contracts in progress3€163k€145k▼
Stocks30/36€163k€145k▼
Amounts receivable within one year40/41€125k€135k▲
Trade receivables40€73k€79k▲
Other amounts receivable41€52k€56k▲
Cash at bank and in hand54/58€42k€47k▲
Deferred charges and accrued income490/1€11k€13k▲
Equity and liabilities
Total equity and liabilities10/49€636k€648k▲
Equity10/15€435k€427k▼
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€373k€365k▼
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Tax-exempt reserves132€41k€37k▼
Distributable reserves133€325k€321k▼
Provisions and deferred taxes16€14k€12k▼
Deferred taxes168€14k€12k▼
Amounts payable17/49€187k€209k▲
Amounts payable after more than one year17-€24k
Financial debts170/4-€24k
Amounts payable within one year42/48€186k€182k▼
Current portion of amounts payable after more than one year42-€6k
Trade debts44€70k€72k▲
Suppliers440/4€70k€72k▲
Taxes, remuneration and social security45€23k€11k▼
Taxes450/3€6k€50▼
Remuneration and social security454/9€17k€10k▼
Other amounts payable47/48€94k€94k▲
Accrued charges and deferred income492/3€933€3k▲
Income statement
Code20242025
Remuneration, social security and pensions62€95k€103k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€22k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€6k€8k▲
Other operating charges640/8€2k€3k▲
Gross operating margin9900€111k€137k▲
Operating profit (loss)9901€-10k€2k▲
Financial income75/76B€2k€1k▼
Recurring financial income75€2k€1k▼
Financial charges65/66B€10k€13k▲
Recurring financial charges65€10k€13k▲
Profit (loss) for the period before taxes9903€-18k€-10k▲
Transfer from deferred taxes780€1k€1k=
Profit (loss) for the period9904€-17k€-8k▲
Transfer from tax-exempt reserves789€4k€4k=
Profit (loss) for the period to be appropriated9905€-13k€-4k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-13k€-4k▲
Transfer from equity791/2€13k€4k▼
Social balance
Average headcount (FTE)90871.31.5▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
22-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 22 days late
2024
31-12
Financial
Weakest financial yearnet €-17k ▼142%
Net result drops to €-17k, the lowest in the series; recovery starts the following year.
12-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 12 days late
2023
28-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Equity above €500kEq €512k ▲3.9%
5 profitable years in a row build equity to €512k.
20-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
26-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Highest result since 2018net €88k ▲216%
Operating result €118k, net result €88k, both a record.
04-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
28-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 28 days late
2018
20-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 20 days late
2017
10-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 10 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zedelgem · 1 establishment unit since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rijselsestraat 298210 ZedelgemGround area
749 m²
Building footprint
185 m²
Volume, LiDAR
1,128 m³
Parcel 31017B0312/00E002, Flanders · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK LOPPEM NV
since 20022.037.767.684
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31017B0312/00E002 | Flanders | 749 m² | 1 · 185 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteZedelgem2.037.767.684
Similar companies · same sector, comparable size
DOMICAPHARMA
BE 0798.126.193
Sint-Laureins · Eq €426k
PHARMACIE MANDRAGORE
BE 0452.802.037
Quaregnon · Eq €427k
APOTHEEK CZIJZ-BATSELIER
BE 0874.514.188
Gent · Eq €426k
APOTHEEK WILDERT
BE 0479.870.876
Essen · Eq €427k
MV PHARMA
BE 0673.532.069
Saint-Ghislain · Eq €426k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,419 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded22-12-1983
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 42 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.